Treatment of mucor infection after liver or pancreas-kidney transplantation

Transplantation Proceedings

Volumn 34, Issue 1, 2002, Pages 82-83

  Jimenez C ^a   Lumbreras, C ^a   Paseiro, G ^a   Loinaz, C ^a   Romano, D R ^a   Andres A ^a   Aguado, J M ^a   Morales, J M ^a   Del Palacio, A ^a   Garcia I ^a   Moreno, E ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; METHYLPREDNISOLONE; OKT 3; STEROID; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEBRIDEMENT; DIABETES MELLITUS; DISEASE ASSOCIATION; DOSE RESPONSE; FUNGUS CULTURE; GRAFT REJECTION; HUMAN; INFECTION RISK; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG CANCER; MALE; MALNUTRITION; MUCORMYCOSIS; PANCREAS TRANSPLANTATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME;

ADULT; HUMANS; INCIDENCE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MUCORMYCOSIS; PANCREAS TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RHIZOPUS;

EID: 0036228097     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(01)02676-8     Document Type: Article

References (14)